Showing results (51-60 of 292) with videos related to

Sort By:
Pageof 30
Journal of Pharmaceutical Sciences|October 7, 2023
PBPK Modeling of PAXLOVIDTM: Incorporating Rotamer Conversion Kinetics to Advanced Dissolution and Absorption ModelRohit Jaini, Jian Lin, Li Di, et al.
Current Drug Metabolism|November 11, 2008
In vitro solubility assays in drug discoveryEdward H Kerns, Li Di, Guy T Carter
Current Pharmaceutical Design|July 16, 2009
Drug-like property concepts in pharmaceutical designLi Di, Edward H Kerns, Guy T Carter
Nature Reviews. Drug Discovery|December 2, 2010
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discoveryDennis A Smith, Li Di, Edward H Kerns
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Consideration of the unbound drug concentration in enzyme kineticsNigel J Waters, R Scott Obach, Li Di
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|June 21, 2012
[Functional divergence of betaine aldehyde dehydrogenase genes in Populus euphratica]Jiaqi Liu, Xue Yang, Li Di, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Consideration of the Unbound Drug Concentration in Enzyme KineticsNigel J Waters, R Scott Obach, Li Di
Expert Opinion on Drug Discovery|March 20, 2013
Strategies to assess blood-brain barrier penetrationLi Di, Edward H Kerns, Guy T Carter
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2024
Low molecular weight acids and OATP1B mediated hepatic clearance: In vitro and in vivo evaluation using novel hypoxia-inducible factor prolyl hydroxylase inhibitors (Dustats)Yi-An Bi, Samantha Jordan, Amanda King-Ahmad, et al.
Experimental Dermatology|March 3, 2021
Ex vivo gene modification therapy for genetic skin diseases-recent advances in gene modification technologies and deliveryVignesh Jayarajan, Evangelia Kounatidou, Waseem Qasim, et al.
Pageof 30